AC-262 is a lesser-known selective androgen receptor modulator. Many lifters overlook it because louder names dominate the scene. Yet AC-262 sits quietly in the background with an interesting profile. It has partial agonist activity at the androgen receptor. It shows anabolic effects in muscle with less action on the prostate in animal models. In the Miracle Molecule world, that balance can be useful. This article will explore what AC-262 is, how it works, how it compares to popular options like ostarine, and where it can fit in an experimental toolkit.
Tony Huge talks about “miracle molecules” as strategic tools to move the body between performance modes. AC-262 fits that view well. It aims for muscle and bone while trying to spare other tissues. It is not approved for medical use. It belongs to the category of experimental SARMs. Readers should treat it as research grade only. Still, for biohackers who study these compounds, AC-262 offers a unique option.
What Is AC-262?
AC-262, also called AC-262536, is a nonsteroidal compound developed in the SARM era by Acadia Pharmaceuticals. Researchers identified it as a selective androgen receptor ligand. It activates the receptor as a partial agonist. In preclinical models, it increased levator ani muscle weight to about two thirds of the effect of testosterone while raising prostate weight by roughly one quarter of testosterone’s effect. That pattern is the goal of a SARM. You want muscle and bone gains with reduced androgenic side effects.
AC-262 is often classed with other experimental SARMs like RAD-140 and ACP-105. Chemically, it shows endo and exo isomers, with the endo form being active. For most readers, the main takeaway is simple. AC-262 binds well to the androgen receptor and signals growth. It does so with a ceiling effect because it is a partial agonist. That can reduce the risk of overactivation in unwanted tissues. It may also cap the peak gains compared with full agonists or high dose steroids.

How AC-262 SARM Works: Mechanism and Selectivity
Understanding how AC-262 talks to the androgen receptor helps you use it with intent. This section explains its partial agonist action, why selectivity matters, and what that means for muscle, bone, and side effects in real life.
Partial agonist with tissue selectivity
The androgen receptor sits inside target cells. When a ligand binds, the receptor moves to the nucleus and turns on genes that control muscle protein synthesis, bone remodeling, and many other functions. AC-262 acts as a partial agonist. It turns the receptor on, but not to the maximum level of testosterone or dihydrotestosterone. This partial signal can be enough to drive muscle growth with a smaller effect in tissues like the prostate and skin.
What that means in practice
- AC-262 may support lean mass and strength through increased protein synthesis.
- It may aid bone health by supporting androgen-driven remodeling.
- It is less likely to cause prostate stimulation compared with testosterone in animal models.
- It can still suppress natural testosterone because the hypothalamus reads androgenic signaling and reduces LH and FSH. Most experimental SARMs share this property to a degree.
These points place AC-262 in the “calibrated push” category. It nudges androgen signaling up without fully flooring the gas pedal.
AC-262 vs Popular SARMs
Not all SARMs feel the same in the gym or in your bloodwork. Here, we compare AC-262 with ostarine and RAD-140 so you can match the tool to your goal, risk tolerance, and timeline.
AC262 vs Ostarine: Which SARM Fits Your Goal
Ostarine, also called GTx-024 or MK-2866, is the most known entry-level SARM. It reached human clinical trials for muscle wasting. In those studies, ostarine increased lean body mass and improved physical function measures like stair-climb power. That human data built trust among early adopters. AC-262 does not have the same level of human outcome data. It lives more in the preclinical and research space. This is the main reason AC-262 is less famous.

So how do they compare in practice for a biohacker who studies experimental sarms?
- Evidence base: Ostarine has published human trials. AC-262 has preclinical data and analytical detection studies. That does not mean AC-262 is weak. It means less clinical certainty.
- Potency and selectivity: AC-262 shows strong receptor binding and tissue selectivity in animals. Ostarine also shows selectivity and has translated this into measured lean mass in people.
- Suppression: Both can suppress natural testosterone and LH to some degree. Partial agonism does not remove this risk.
- Use case: Ostarine fits conservative first experiments because of human data and many anecdotal logs. AC-262 fits a niche for those who want a different receptor engagement profile and who follow a Miracle Molecule style protocol.
AC-262 vs RAD-140
RAD-140 is powerful. Users often report rapid strength and size changes. It also carries more suppression and side effect reports. AC-262 looks milder and more measured. If RAD-140 is a sledgehammer, AC-262 is a precision wrench. In a Miracle Molecule plan, you might select AC-262 for a recomp or cruise-like phase, and RAD-140 for a short hard push. This is strategy, not a claim of safety.

Benefits of AC-262 SARM for Muscle, Bone, and Recomp
AC-262 aims to drive lean growth while keeping androgenic noise lower than stronger agents. Review the key benefits you can expect when training, nutrition, and recovery are aligned.
Lean mass and strength
AC-262 can support muscle protein synthesis. In animal models it produced meaningful anabolic effects. In the gym, the expected benefit is small but steady increases in lean mass and strength when training and nutrition are on point.
Recomp support
Because it is a partial agonist, many users position AC-262 for recomp. You can hold muscle while dieting and sometimes add small amounts of lean tissue. This depends on your calories, protein, and training intensity.
Joint and connective comfort
Androgen signaling can improve collagen turnover. A gentle SARM signal may improve training comfort for some users. It is not a medical treatment for injury. It is a possible side benefit seen with androgens in general.
Stack flexibility in the Miracle Molecule approach
Tony Huge teaches mode-based enhancement and pendulum swings between push and recovery. AC-262 fits well in a mild push or a bridge phase. It can also pair with growth-hormone–oriented protocols, insulin-sensitizing agents, or nutrient partitioners. It supports muscle retention while the rest of the stack handles appetite, sleep, and recovery.
Risks and Side Effects of Experimental SARMs
Every experimental SARM carries trade offs. Learn the main risks, what labs to watch, and the current regulatory landscape so you can make informed decisions.
Endocrine suppression
Even partial agonists can suppress the HPT axis. Users can see drops in LH, FSH, and total testosterone. The degree varies with dose and duration. Plan your bloodwork. Plan your off time. Some add a SERM like enclomiphene after a research phase. Others design time-off windows in a pendulum model.
Lipids and liver enzymes
Many experimental SARMs can lower HDL and raise AST or ALT. Monitor labs. Support your liver with sleep, hydration, and nutrition. Use TUDCA or NAC if your protocol calls for it.
Unknowns due to limited human data
AC-262 has fewer human data than ostarine. Long term effects are not well described. This uncertainty is the price of operating in the experimental zone. Respect that risk.
Where AC-262 Fits in the Miracle Molecules Strategy?
Miracle Molecules use a pendulum approach that moves between push and recovery. See where AC-262 adds value inside recomp, bridge, and lean bulk modes without overwhelming the system.
AC-262 for Natty+ style progress
Tony Huge separates tools by impact and risk. In that style, AC-262 acts like a Natty+ lever. It is not as natural as creatine or epicatechin. It is also not as heavy as full steroid cycles. You can build a smart stack that uses AC-262 as the androgen backbone and then layers in safer support molecules.
Example concepts:
- Recomp mode: AC-262 with MK-677 for sleep and GH pulses. Add SLIN Pills or berberine around carb meals. Add creatine and EAAs daily. Train with progressive overload. Keep a slight calorie deficit. Track strength and waist.
- Lean bulk mode: AC-262 with higher protein and a small calorie surplus. Use arachidonic acid pre training to enhance the inflammatory signal that drives hypertrophy. Keep insulin sensitivity high with daily steps and a GDA with the largest carb meals.
- Bridge mode: AC-262 with enclomiphene at low dose to support endogenous testosterone signaling while reducing total androgen burden. Keep cardio, sleep, and micronutrients tight.
These ideas follow the pendulum method. Push. Then recover. Repeat. The molecule is a tool. The protocol decides the outcome.
AC-262 SARM Dosing Philosophy
Dose with purpose, not ego. This section outlines common community ranges, a start low approach, and the essential blood tests that guide safer experimentation.
- Common research ranges: Many online logs for AC-262 mention 10 to 20 mg per day for 6 to 8 weeks. That mirrors what you see in community protocols for other mild SARMs.
- Minimum effective dose first: Start low in any research plan. Increase only when needed. The goal is results with the least burden.
- Cycle length: Shorter cycles reduce suppression and give you more data points. Eight weeks on and a proper off period is a common pattern in community reports.
- Bloodwork: Test before, mid cycle, and after. Track total testosterone, free testosterone, LH, FSH, estradiol, lipid panel, liver enzymes, hematocrit, and fasting glucose.
Again, AC-262 is an experimental compound. Treat it with the same respect you would give a prescription drug.
AC-262 Body Composition Strategy: Training, Nutrition, Recovery
Chemistry works best when your plan supports it. Align your training, calories, and recovery habits with AC-262 to keep strength rising and body fat moving the right way.
Training alignment
Your training should match your chemistry. With a gentle SARM like AC-262, use progressive tension overload. Keep reps in the eight to fifteen range for most sets. Push close to failure but keep form tight. Add one strength day where you work in the five to eight range. This drives neural gains that improve rep numbers the rest of the week.
Nutrition alignment
- Protein: Two grams per kilogram of body weight per day is a simple target for most users.
- Carbs: Time most carbs around training and the post workout window. Use low glycemic sources the rest of the day.
- Fats: Do not crash dietary fat. Hormones need fat. Aim for 0.8 grams per kilogram per day as a floor during a long cut.
- Supplements: Creatine, EAAs, electrolytes, magnesium, and vitamin D are baseline supports.
Recovery alignment
Sleep is the multiplier. MK-677 can improve sleep depth for some users by raising growth hormone. Keep caffeine earlier in the day. Add a simple sleep stack at night like glycine plus magnesium glycinate.
Advanced Comparison: AC-262 vs Ostarine for Cutting and Recomp
- Cutting: Ostarine has more human data for lean mass retention during calorie deficits. AC-262 offers a partial agonist route with potentially less androgenic noise. For a strict cut, the choice may depend on your tolerance for uncertainty.
- Recomp: AC-262 may shine here because of its steady signal and stack flexibility. It fits well with insulin sensitizers, GLP-1 agonist research compounds, or fat loss agents that control appetite. It is less likely to drive huge appetite increases, which helps during recomp.
- Bridging: AC-262 can act as a bridge tool between heavy phases. Ostarine can do this too, but many prefer variety to avoid receptor fatigue and to gather new data.
Practical Notes for Experimental SARMs Users
- AC-262 is detectable. Anti-doping agencies list SARMs as banned. Do not use if you are subject to drug testing.
- AC-262 is not a supplement. It is not a food. It is not approved for human use. Treat it as a research chemical.
- AC-262 stacks best with lifestyle mastery. You cannot out-supplement poor sleep or poor training.
- AC-262 is not hair safe. Androgen signaling can accelerate hair shedding in men with genetic risk. Monitor and decide based on your priorities.
AC-262 Miracle Molecules Research Framework
This is a study template for educational use only. It shows how an advanced user might structure weeks on and off, track data, and keep the pendulum swinging forward.
Weeks 1 to 8
- AC-262 at a low starting dose, titrated based on response logs
- Creatine 5 g per day
- MK-677 10 mg at night, three days on and one day off to manage water and insulin sensitivity
- SLIN Pills or berberine with high carb meals
- Arachidonic acid pre workout on training days
- Cardio 30 minutes daily at a steady pace
- Training four days per week with progressive overload
Off period 4 to 6 weeks
- Enclomiphene at a low dose if labs show suppression
- High steps and low stress
- Liver support with TUDCA and NAC if enzymes rose
- Keep creatine, protein, and sleep consistent
Data tracking
- Scale weight and waist twice per week
- Strength on three core lifts
- Morning wood and mood as simple endocrine markers
- Bloodwork at least twice
This is a pendulum. Push. Reset. Push again. The goal is steady forward motion with minimal side effects.
Who Should Avoid AC-262 SARM
- Tested athletes
- People with prostate issues or a family history of prostate cancer
- People with uncontrolled lipid disorders or liver disease
- Anyone without access to reliable bloodwork
- Anyone who is not willing to stop at the first sign of adverse effects
Final Thoughts on AC-262 SARM
AC-262 is the quiet SARM. It does not dominate social media. It does not have splashy human trials like ostarine. But AC-262 brings a balanced, partial agonist style that appeals to strategic biohackers. In the Miracle Molecule mindset, it is a tool for controlled progress. It supports lean mass while keeping the overall burden lower than stronger agents when used carefully. It works best when stacked with strong fundamentals. Sleep, food quality, and smart training remain the base.
Tony Huge and the Miracle Molecule community push for intelligent experimentation. They reward tools that give more than they take. AC-262 can be one of those tools when used with respect. Not every reader should pursue it. For the open minded researcher, it deserves a second look.
Frequently Asked Questions (FAQs)
Is AC-262 legal to use?
No. AC-262 is not approved for human use. SARMs are prohibited in sport and appear on the WADA Prohibited List. Products marketed as supplements that contain SARMs have received FDA warning letters.
Does AC-262 cause suppression?
Yes. Like other experimental SARMs, AC-262 can suppress natural testosterone to some degree. Plan your off time. Use bloodwork to guide decisions.
Is AC-262 better than ostarine?
It depends on your goal. Ostarine has human trial data and a large body of user logs. AC-262 has a partial agonist profile that some prefer for recomp or bridge phases. The trade off is less human data.
Can women study AC-262?
Women face androgenic side effects like voice changes, acne, and hair growth. Because AC-262 is experimental, the risk is hard to quantify. Women should be very cautious and should consider safer options.
What dose is common in community logs?
Many logs mention 10 to 20 mg daily for 6 to 8 weeks. This is not a recommendation. It is a report of what people discuss online.
Will AC-262 help fat loss?
It can help preserve muscle in a calorie deficit. That supports fat loss by maintaining metabolic rate and training output. True fat loss still comes from diet and activity.